GlassScriptPhysician profile
Neha Verma
NPI 1538569355
$875.36
in general payments reported to CMS, 2019-2025
16 companies · $299 in 2025
The $299 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $145 · 2021: $59.08 · 2023: $114 · 2024: $258 · 2025: $299.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $632 · Education: $39.56.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $631.98 |
| Education | $39.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $189.86 | 2021-2025 | Minimed 780g |
| Dexcom, INC. | $176.00 | 2024-2025 | Dexcom G6 Transmitter |
| Novo Nordisk INC | $116.70 | 2023-2025 | Rybelsus, Ozempic, Wegovy |
| Corcept Therapeutics | $81.48 | 2024 | Korlym |
| Astrazeneca Pharmaceuticals LP | $43.48 | 2019 | |
| Pfizer INC. | $42.03 | 2019 | |
| Madrigal Pharmaceuticals | $39.56 | 2025 | Rezdiffra |
| Lilly USA, LLC | $34.10 | 2019-2025 | Zepbound, Mounjaro |
| Tandem Diabetes Care, INC. | $28.67 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Sanofi-Aventis U.S. LLC | $23.22 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $20.03 | 2023 | Jynarque |
| Ascendis Pharma Endocrinology INC | $17.97 | 2025 | Yorvipath |
| Alexion Pharmaceuticals, INC. | $16.57 | 2023 | Strensiq |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.69 | 2019 | |
| Mannkind Corporation | $15.59 | 2023 | Afrezza |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuity Medical INC | $14.41 | 2023 | Pogo Automatic Blood Glucose Monitoring System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neha Verma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.